Altamira Therapeutics Ltd. (CYTOF)
OTCMKTS · Delayed Price · Currency is USD
0.0502
+0.0002 (0.40%)
Apr 7, 2026, 10:11 AM EST
Altamira Therapeutics Employees
Altamira Therapeutics had 11 employees as of December 31, 2024. The number of employees increased by 1 or 8.65% compared to the previous year.
Employees
11
Change (1Y)
1
Growth (1Y)
8.65%
Revenue / Employee
n/a
Profits / Employee
-$513,903
Market Cap
286.92K
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 11 | 1 | 8.65% |
| Dec 31, 2023 | 10 | -6 | -36.20% |
| Jan 1, 2023 | 16 | 2 | 12.41% |
| Dec 31, 2021 | 15 | 6 | 79.01% |
| Dec 31, 2020 | 8 | 0 | - |
| Dec 31, 2019 | 8 | -2 | -15.63% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Abpro Holdings | 15 |
| Windtree Therapeutics | 14 |
| Ampio Pharmaceuticals | 6 |
| Innovation Pharmaceuticals | 4 |
| GB Sciences | 2 |
| Actavia Life Sciences | 1 |
| Regen BioPharma | 1 |
Altamira Therapeutics News
- 8 days ago - Altamira Therapeutics Provides Business Update and Reports Full Year 2025 Financial Results - Accesswire
- 15 days ago - Altamira Therapeutics Announces Release Date for 2025 Annual Report and Financial Statements - Accesswire
- 7 weeks ago - Altamira Therapeutics Announces Allowance of Japanese Patent Application Covering Bentrio Nasal Spray - Accesswire
- 2 months ago - Altamira Therapeutics to Present at mRNA-Based Therapeutics Summit - Accesswire
- 3 months ago - Altamira Therapeutics Announces Market Approval of Bentrio Nasal Spray in China - Accesswire
- 4 months ago - Altamira Therapeutics Announces Certification of Bentrio Nasal Spray under Medical Device Regulation - Accesswire
- 5 months ago - Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of DNA Molecules - Accesswire
- 7 months ago - Altamira Therapeutics Provides Business Update and First Half 2025 Financial Results - Accesswire